Here's looking at the best discoveries in a year that kept us indoors.

Biotechnology major Biocon today concluded sale of 10 per cent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Pr...

'Syngene is India’s leading research services company in discovery and development space, especially in the pharmaceutical sector,' says Ma...

This transaction is part of the overall strategic plan for Syngene and sets a new benchmark as we prepare the company for listing, Kiran ad...